Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers

PURPOSE: The objective of this study was to estimate the risk of contralateral breast cancer in BRCA1 and BRCA2 carriers; and measure the extent to which host, family history, and cancer treatment-related factors modify the risk. PATIENTS AND METHODS: Patients were 810 women, with stage I or II brea...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Metcalfe, K, Gershman, S, Lynch, H T, Ghadirian, P, Tung, N, Kim-Sing, C, Olopade, O I, Domchek, S, McLennan, J, Eisen, A, Foulkes, W D, Rosen, B, Sun, P, Narod, S A
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2011
Témata:
Clinical Study
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3101934/
https://ncbi.nlm.nih.gov/pubmed/21487411
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2011.120
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky